Gary M. Saxton

DVI Inc. provides medical procedures such as diagnostic imaging and radiation therapy. The company conducts its business principally through two operating subsidiaries DVI Financial Services Inc and DVI Business Credit Corporation. The company was founded in 1986 and is located in Jamison, PA.

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

Harvest Capital Strategies LLC (Harvest) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1999 and formerly known as JMP Asset Management LLC. They are wholly owned by JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Harvest provides discretionary investment advisory services to a number of private investment funds that operate as private investment funds.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

CathRx Ltd. manufactures and develops electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias. Its products include ablation EP catheters, loop EP catheters, steerable EP catheters, and fixed EP catheters. The company was founded on 31st August, 1999 and is headquartered in Homebush Bay, Australia.

Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT.

Choice Therapeutics, Inc. develops and manufactures pharmaceuticals. It also conducts research and development to find novel medicines. The company is headquartered in Wrentham, MA.

ProMed, Inc. develops products for OB/GYN, orthopedic and aesthetic applications. The company was founded on May 10, 2007 and is headquartered in Temecula, CA.

Hotspur Technologies, Inc. manufactures medical devices and supplies for the dialysis treatment. The company was founded by James Howard Dreher, Jeffrey A. Krolik and Fred Khosravi in 2008 and is headquartered in Wayne, PA.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million.

CardioFocus, Inc. engages in the development and market of catheter-based approach to treating atrial fibrillation. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.

Medtronic CardioVascular manufactures medical devices. Its products include dru-eluting stents, guide catheters, guidewires and balloon diagnostic catheters to treat diabetes, heart disease, neurological disorders and vascular illnesses. The company is headquartered in Santa Rosa, CA.

SmartPill Diagnostic, Inc. manufactures ingestible, capsule-based medical devices for gastrointestinal disorders and diseases. The firm product is SmartPill GI Monitoring System that assist physicians and researchers in the evaluation of gastroparesis and chronic constipation, GI motility disorders . The company was founded in 1999 and is headquartered in Buffalo, NY.

Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX.

Empirical Spine, Inc. develops minimally invasive, flexion-restricting stabilization devices for the spine. It offers LimiFlex Spinal Stabilization System which is a novel implant that provides segmental stability to the lumbar spine while still allowing motion and also used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis. The company was founded by Louis Fielding, John Colin Cahill, Ian Bennett and Todd F. Alamin in 2006 and is headquartered in San Carlos, CA.

Allied Minds LLC (Allied Minds) is a venture capital subsidiary of Allied Minds Plc founded in 2006 by Mark A. Pritchard. The firm is headquartered in Boston, Massachusetts.

N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.

Exotech Bio, Inc. develops RNA therapeutic for cancer treatment. The company is headquartered in San Francisco, CA.

Thrive Agrobiotics, Inc. engages in research and development by utilizing gut cell therapy platform. The company is headquartered in San Francisco, CA.

AD Skincare, Inc. provides skincare health services. The company is headquartered in San Francisco, CA.

CRS Bio, Inc. engages in the provision of biotechnology products. The company was founded in 2016 and is headquartered in San Francisco, CA.

Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA.

Koch Disruptive Technologies LLC (Koch Disruptive Technologies) is a venture capital firm subsidiary of Koch Industries Inc founded in 2017. The firm is headquartered in Wichita, Kansas.